60
In band
Moving averages
SMA 200$56.53+231.61%
Company profile
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$57.48B
P/E ratioNone
EPS$-8.41
Beta1.106
Dividend yield0.00%
52-week high$176.66
52-week low$22.28
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 43
VRTX
Vertex Pharmaceuticals Inc
RSI 38
CRSP
CRISPR Therapeutics AG
RSI 46
IOVA
Iovance Biotherapeutics Inc
RSI 66
VKTX
Viking Therapeutics Inc
RSI 39
SRPT
Sarepta Therapeutics Inc
RSI 37
EDIT
Editas Medicine Inc
RSI 49
IBRX
ImmunityBio Inc
RSI 61
NVAX
Novavax Inc
RSI 60
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 63
RSI alerts for MRNA
Get an email the moment Moderna Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 5:34 AM EDT